Your session is about to expire
← Back to Search
SaFTiE for EMS Worker Fatigue (SaFTiE Trial)
N/A
Waitlist Available
Led By P. Daniel Patterson, PhD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
18 years or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 6 months
Awards & highlights
SaFTiE Trial Summary
This trial is testing a new approach to reducing fatigue among EMS workers, which is a big problem because it leads to more injuries on the job.
Who is the study for?
This trial is for EMS workers who are over 18, live in the US, do clinical shifts weekly, and can respond to surveys and texts. They must be licensed/certified clinicians working in shifts with a smartphone. Those mainly in administrative roles or without a compatible smartphone are excluded.Check my eligibility
What is being tested?
The study tests 'SaFTiE', an approach to manage fatigue risk among EMS workers against an attention placebo control. It aims to see if SaFTiE is cost-effective and scalable while reducing work-related mental and physical fatigue.See study design
What are the potential side effects?
Since this trial focuses on behavioral interventions rather than medications, traditional side effects like those seen with drugs aren't expected. However, participants may experience changes in sleep patterns or stress levels due to adjustments in managing fatigue.
SaFTiE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
SaFTiE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Fatigue
Secondary outcome measures
Fatigue
Poor Sleep Quality
SaFTiE Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: SaFTiEExperimental Treatment1 Intervention
The SaFTiE intervention includes: [a] real-time text-message assessments of fatigue and sleep during and between scheduled shift work; [b] tailored text-message alerts that promote adopting evidence based strategies for mitigating fatigue when high levels of fatigue or sleepiness are reported; [c] a mobile app that delivers goal setting, summary data of sleep/fatigue indicators from all study participants, and video interviews of EMS clinicians focused on sleep and fatigue.
Group II: Attention Placebo ControlPlacebo Group1 Intervention
The attention placebo control includes: [a] real-time text-message assessments of teamwork during and between scheduled shift work; [b] text-message alerts that promote techniques for mitigating poor teamwork when episodes of poor teamwork are reported; [c] a mobile app that delivers goal setting, summary data of teamwork indicators from all study participants, and video interviews of EMS clinicians focused on teamwork.
Find a Location
Who is running the clinical trial?
University of PittsburghLead Sponsor
1,722 Previous Clinical Trials
16,342,228 Total Patients Enrolled
11 Trials studying Fatigue
1,560 Patients Enrolled for Fatigue
National Institute for Occupational Safety and Health (NIOSH/CDC)FED
41 Previous Clinical Trials
48,831 Total Patients Enrolled
1 Trials studying Fatigue
80 Patients Enrolled for Fatigue
P. Daniel Patterson, PhDPrincipal InvestigatorUniversity of Pittsburgh
1 Previous Clinical Trials
28 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am willing to answer daily texts and monthly surveys.I work at least one clinical shift every week.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: SaFTiE
- Group 2: Attention Placebo Control
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the scale of participation in this medical experiment?
"Affirmative. Information published on clinicaltrials.gov verifies the active recruitment of patients for this medical study, which was posted online on September 16th 2020 and last updated two years later. The trial hopes to recruit 1900 individuals at 1 site."
Answered by AI
Is this research currently accepting participants?
"Affirmative. The information on clinicaltrials.gov attests to the fact that this medical study, which was first advertised on September 16th 2020, is still searching for participants. Currently 1900 individuals need to be enrolled from 1 facility."
Answered by AI
Share this study with friends
Copy Link
Messenger